Table 2 Patient baseline characteristics and pre-operative treatment
n | 37 | |
Age; years | 69.3 ± 9.5 | |
Height; cm | 175.1 ± 8.7 | |
Weight; kg | 83.7 ± 1 8.5 | |
BMI; kg.m−2 | 27.2 ± 5.0 | |
Sex; female | 8 (21.6) | |
EuroSCORE II | 1.7 [1.0 to 4.1] | |
Preoperative anticoagulation/platelet inhibition | preoperative stop | |
Acetylsalicyl acid (single drug) | 16 (43.2) | 0 |
Acetylsalicyl acid + Clopidogrel | 3 (8.1) | 1 (33.3) |
Acetylsalicyl acid + Apixaban | 1 (2.7) | 1 (100) |
DOAC (single drug) | 5 (13.5) | 5 (100) |
LMWH (single drug) | 3 (8.1) | 0 |
Phenprocoumon (single drug) | 2 (5.4) | 1 (50) |
Clopidogrel + LMWH | 1 (2.7) | 1 (100) |
DOAC + LMWH | 1 (2.7) | 1 (100) |
No drug given | 5 (13.5) | |